Live feed
·
PRReleasevia Quantisnow
Hyperfine Inc. logo

Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

ByQuantisnow·Wall Street's wire, on your screen.
HYPR· Hyperfine Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HYPR (Hyperfine Inc.) and more on Quantisnow.